Semigran Marc
Officer at EWTX; Chief Medical Officer at MyoKardia Inc
- Sold, on record
- $3.6M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Dec 24, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- EWTXEdgewise Therapeutics, Inc.Officer
- MyoKardia IncChief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- MyoKardia Inc45,000 shares
- EWTX29,709 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MyoKardia IncUnusualSep 5, 2018 2018
Sold 45,000 shares at $59.53 ($2.7M)
Semigran Marc, Chief Medical Officer
Sold 100% of holdings ($2.7M position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice EWTXNoticeDec 24, 2024 +2302 days
Filed to sell 50,000 shares ($1.5M)
Semigran Marc, Officer
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale EWTXRoutineDec 24, 2024 same day
Sold 29,709 shares at $29.68 ($882k)
Semigran Marc, Chief Development Officer
10b5-1 planSold 81.6% of holdings ($1.1M position)6,716 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Dec 27, 2024 | EWTX | Chief Development Officer | Form 4 sale | 29,709 | $882k | 81.6% | Routine | SEC |
| Dec 24, 2024 | Dec 26, 2024 | EWTX | Officer | Form 144 notice | 50,000 | $1.5M | Notice | SEC | |
| Sep 5, 2018 | Sep 6, 2018 | MyoKardia Inc | Chief Medical Officer | Form 4 sale | 45,000 | $2.7M | 100.0% | Unusual | SEC |